CINECA IRIS Institutional Research Information System

TACITO, ALESSIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.032
EU - Europa 2.809
AS - Asia 1.406
SA - Sud America 187
AF - Africa 117
OC - Oceania 5
Totale 7.556
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.941
IT - Italia 1.447
CN - Cina 465
SE - Svezia 431
SG - Singapore 384
DE - Germania 350
HK - Hong Kong 245
BR - Brasile 169
GB - Regno Unito 128
BG - Bulgaria 104
IN - India 82
CI - Costa d'Avorio 73
CA - Canada 69
AT - Austria 67
RU - Federazione Russa 62
TR - Turchia 59
VN - Vietnam 57
NL - Olanda 47
FR - Francia 42
FI - Finlandia 38
JP - Giappone 26
SN - Senegal 22
BD - Bangladesh 16
PL - Polonia 15
BE - Belgio 14
IR - Iran 10
MX - Messico 10
UA - Ucraina 10
IQ - Iraq 9
ZA - Sudafrica 8
ES - Italia 7
GR - Grecia 7
ID - Indonesia 7
TW - Taiwan 7
AR - Argentina 6
CR - Costa Rica 6
RO - Romania 6
CH - Svizzera 5
KR - Corea 5
PK - Pakistan 5
AU - Australia 4
CZ - Repubblica Ceca 4
HU - Ungheria 4
IL - Israele 4
MA - Marocco 4
RS - Serbia 4
SA - Arabia Saudita 4
AL - Albania 3
AZ - Azerbaigian 3
EC - Ecuador 3
EG - Egitto 3
IE - Irlanda 3
MY - Malesia 3
UZ - Uzbekistan 3
BH - Bahrain 2
BY - Bielorussia 2
CO - Colombia 2
DK - Danimarca 2
DZ - Algeria 2
JO - Giordania 2
KE - Kenya 2
LT - Lituania 2
PA - Panama 2
PE - Perù 2
PT - Portogallo 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
BO - Bolivia 1
CL - Cile 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
IS - Islanda 1
JM - Giamaica 1
KG - Kirghizistan 1
LK - Sri Lanka 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 7.556
Salva come PNG Salva come JPEG
Città #
Ashburn 373
Woodbridge 240
Hong Kong 239
Fairfield 231
Dallas 226
Singapore 205
Milan 199
Chandler 183
Santa Clara 180
Houston 135
Ann Arbor 131
Shanghai 111
Sofia 103
Beijing 100
Seattle 96
Cambridge 86
Wilmington 79
Rome 75
Abidjan 73
New York 73
Vienna 61
Florence 53
Princeton 52
Ottawa 49
Naples 46
Munich 42
Boardman 41
Los Angeles 38
Lawrence 37
Frankfurt am Main 35
Bologna 32
Medford 31
Pisa 30
Redwood City 30
Serra 28
Dearborn 27
Izmir 27
London 27
Nanjing 26
Boulder 25
Istanbul 25
Des Moines 24
Bremen 23
Dakar 22
Redondo Beach 18
Lancaster 17
São Paulo 16
San Diego 15
Tokyo 15
Dong Ket 14
Bengaluru 13
Brussels 13
Palermo 13
Parma 13
Turin 13
Buffalo 12
Helsinki 12
Mumbai 12
Tianjin 12
Bari 11
Hangzhou 11
Jaboatão 11
Verona 11
Changsha 10
Guangzhou 10
Ho Chi Minh City 10
Salerno 10
Bhavnagar 9
Boston 9
Udine 9
Washington 9
Chengdu 8
Council Bluffs 8
Genoa 8
Lucca 8
Trieste 8
Wuhan 8
Acerra 7
Chicago 7
Cuneo 7
Montale 7
Quanzhou 7
Shenzhen 7
Cascina 6
Columbus 6
Fuzhou 6
Jacksonville 6
La Spezia 6
Messina 6
Modena 6
Nanchang 6
Napoli 6
Padova 6
Roubaix 6
San José 6
Toronto 6
Trevignano 6
Zhengzhou 6
Angri 5
Atlanta 5
Totale 4.487
Salva come PNG Salva come JPEG
Nome #
I CARCINOMI PAPILLARI E MIDOLLARI DELLA TIROIDE PRESENTI CONTEMPORANEAMENTE HANNO ORIGINE GENETICA INDIPENDENTE 1.089
L’ANALISI GENETICA DI CARCINOMI PAPILLARI E MIDOLLARI DELLA TIROIDE PRESENTI CONTEMPORANEAMENTE RIVELA LA LORO NATURA CASUALE 323
Celecoxib, a cyclooxygenase-2 inhibitor, potentiates the chemotherapic effect of vinorelbine in the medullary thyroid cancer TT cell line. 270
Celecoxib, a cyclooxygenase-2 inhibitor, potentiates the chemotherapic effect of vinorelbine in the medullary thyroid cancer TT cell line 230
LOW PREVALENCE OF THE SOMATIC M918T RET MUTATION IN MICRO-MEDULLARY THYROID CANCER. 219
In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer 214
V804M RET MUTATION AND VANDETANIB RESPONSE IN METASTATIC MEDULLARY THYROID CANCER 206
A complex MEN2 syndrome, a mixture of 2B and 2A, associated with a new RET germiline deletion. 206
CLINICAL IMPACT OF RET GENETIC SCREENING IN THE MANAGEMENT OF MEDULLARY THYROID CARCINOMA (MTC) PATIENTS: 20 YEARS OF EXPERIENCE 200
Next generation sequencing revealed RET or RAS mutation in medullary thyroid cancer that were negative at sanger sequencing 192
Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma 188
Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma. 187
GENETIC SCREENING OF RET CAN IDENTIFY NEW MUTATIONS EVEN AFTER 20 YEARS 179
A kinetic study of gamma-glutamyltransferase (GGT)-mediated S-nitrosoglutathione catabolism 175
Vandetanib and the predictive factors of durable response in locally advanced or metastatic medullary thyroid cancer: a single center experience. 168
Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma. 163
A kinetic study of gamma-glutamyltransferase (GGT)-mediated S-nitrosoglutathione catabolism 163
Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma 162
null 160
null 157
Mutazione V804M di RET nel carcinoma midollare della tiroide e risposta al trattamento con vandetanib 154
GENETIC LANDSCAPE OF SOMATIC MUTATIONS IN A LARGE COHORT OF SPORADIC MEDULLARY THYROID CARCINOMAS STUDIED BY NEXT GENERATION TARGETED SEQUENCING 153
AFTER 20 YEARS, RET GENETIC SCREENING STILL INDENTIFIES NEW GERMILINE AND SOMATIC MUTATIONS 151
Differential expression of RET isoforms in normal thyroid tissues, papillary and medullary thyroid carcinomas 149
null 146
MON-490 Calcitonin-Based Thyroidectomy Is a Safe Approach in Patients with Germline RET Mutation and Permits to Delay Surgery in Children 145
New insights in the molecular signature of advanced medullary thyroid cancer: Evidence of a bad outcome of cases with double RET mutations 143
Predictive factors of short and long-term vandetanib response in locally advanced or metastatic medullary thyroid cancer: a single center experience 137
RET mutation heterogeneity in primary advanced medullary thyroid cancers and their metastases 136
Fenotipo misto MEN2A/MEN2B da nuova mutazione germinale di RET: prima descrizione clinico-genetica e iconografia 133
Clinical Impact Of Ret Genetic Screening Of In The Management Of Medullary Thyroid Carcinoma (MTC) Patients: 20 Years Of Experience 130
The Mutation Profile Of Medullary Thyroid Carcinoma Can Be Different In Primary And Metastatic Tissues 129
WHOLE EXOME SEQUENCING OF MEDULLARY THYROID CARCINOMA CASES IDENTIFIES 86 VARIATIONS IN GENES POSSIBLY INVOLVED IN TUMORAL TRANSFORMATION 121
Predictors Of Vandetanib Response In The Locally Advanced Or Metastatic Medullary Thyroid Cancer: A Single Center Experience 118
After 20 Years, RET genetic screening still identifies new germline and somatic mutations 114
A novel fusion RET/PTC3 involving NCOA4 and RET genes in a pediatric case of Papillary Thyroid Carcinoma 108
Genetic heterogeneity of Medullary Thyroid Carcinoma 91
SIMULTANEOUS MEDULLARY AND PAPILLARY THYROID CARCINOMAS SHOW INDEPENDENT GENETIC ORIGIN 85
Low prevalence of the somatic M918T RET mutation in micro-medullary thyroid cancer. 84
Whole Exome Sequencing of Medullary Thyroid Carcinomas did not identify oncogenic drivers alternative to RET and RAS genes 83
null 75
null 70
Ret Oncogene and Thyroid Carcinoma 68
null 58
Totale 7.632
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.916
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.916
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021212 0 0 0 0 0 32 16 28 34 23 27 52
2021/2022631 23 28 15 57 129 62 23 38 40 15 53 148
2022/20231.034 135 155 71 71 76 96 53 65 180 33 72 27
2023/2024888 93 69 68 62 102 122 84 64 50 39 47 88
2024/20251.636 51 81 50 114 183 177 133 107 148 184 144 264
2025/2026963 136 207 214 133 171 102 0 0 0 0 0 0
Totale 7.632